Definium Therapeutics, Inc. (MNMD) at a glance

Definium Therapeutics, Inc. (MNMD) is a mid-cap Healthcare company. It trades at $40.98, with a 0% profit margin. It does not pay a dividend. Vestovix scores it 38/100 overall. Its strongest dimension is Momentum (71/100) and its weakest is Safety (1/100). It carries above-market volatility, so expect larger swings.

Price

$40.98

Market cap

$2.41B

P/E ratio

n/a

Dividend yield

None

Beta

2.62

52-week range

$8.70 to $49.70